Ioflupane (I-123)

Ioflupane (I-123) is a radiopharmaceutical for the diagnosis of Parkinson disease and its differential diagnoses.


  • iodine-123 is a cyclotron product
  • physical half-life is 13.22 hours
  • predominant energy of its gamma spectrum is 159 keV

Ioflupane is the international non-proprietary name of a phenyltropane compound (FPCIT), a cocaine analogue. Ioflupane has a high affinity for presynaptic dopamine transporters which are abundant in the striatal region.

I-123 ioflupane is available worldwide and marketed under the trade name DaTSCAN TM.

Uses, doses and timing

  • as a cyclotron product, the solution is supplied ready to inject
  • the dose reference activity of I-123 ioflupane is 185 MBq (5 mCi)
  • administration is intravenous
  • thyroid blocking with 120 mg potassium iodide 2 hours before and 24 hours after the injection is recommended
  • SPECT scanning typically is performed 3-6 hours after injection
Physics and imaging technology: nuclear medicine
Share article

Article information

rID: 23245
Synonyms or Alternate Spellings:
  • FP-CIT

Support Radiopaedia and see fewer ads

Updating… Please wait.

Alert accept

Error Unable to process the form. Check for errors and try again.

Alert accept Thank you for updating your details.